Thursday, November 10, 2022

Pfizer Chief Boasts Covid Will Continue to Be a “Multi-Billion Dollar Franchise for Years to Come” as Firm Sticks 10,000% Mark-Up on Vaccine

 "The company announced last month it will triple the price of its shot to up to $130 per dose next year – a far cry from the roughly $19 to $30 per dose that the Government paid. Some experts estimate each individual shot to cost just $1.18 to make – meaning the new price represents a 10,000% markup. Analysts speculate that the move was made so Pfizer could still meet its target of $32 billion of projected vaccine revenue this year.  Critics say that the decision shows the firm’s greed. Peter Maybarduk, Director of Access to Medicines at Public Citizen, told DailyMail.com that the firm was already in a good of financial position that it could take some loss. Maybarduk also said that the firm has already made an “obscene” amount of money, and will be “okay” if they do not meet revenue projections that were likely inflated anyway. Pfizer was an early winner during the pandemic when it became the first company to get a COVID-19 vaccine approved for the U.S. market. Subsequent vaccine mandates for healthcare workers and the military further drove up sales of vaccines."